Page 63 - Read Online
P. 63

Page 380                                                      Sale et al. Cancer Drug Resist 2019;2:365-80  I  http://dx.doi.org/10.20517/cdr.2019.14

               48.  Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr
                   2015;9:317-24.
               49.  Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting
                   inactivation of premature senescence. Cancer Cell 2008;14:79-89.
               50.  Liu  Y,  El-Naggar  S,  Darling  DS,  Higashi  Y,  Dean  DC.  Zeb1  links  epithelial-mesenchymal  transition  and  cellular  senescence.
                   Development 2008;135:579-88.
               51.  Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, et al. Epidermal growth factor receptor and mutant p53 expand
                   an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res
                   2010;70:4174-84.
               52.  Singh  A,  Settleman  J.  EMT,  cancer  stem  cells  and  drug  resistance:  an  emerging  axis  of  evil  in  the  war  on  cancer.  Oncogene
                   2010;29:4741-51.
   58   59   60   61   62   63   64   65   66   67   68